Related Experiment Video
Updated: Aug 17, 2026

Use of the EpiAirway Model for Characterizing Long-term Host-pathogen Interactions
Published on: September 2, 2011
The longitudinal approach to the pathogenesis of respiratory disease
Insights
Respiratory syncytial virus (RSV) infection offers temporary resistance, while Mycoplasma pneumoniae infections show age-dependent immune responses. Vaccines may alter disease severity rather than prevent infection.
Area of Science:
- Pediatric Infectious Diseases
- Immunology of Respiratory Infections
Background:
- Respiratory syncytial virus (RSV) and Mycoplasma pneumoniae are common childhood respiratory pathogens.
- Understanding their pathogenesis and immune response is crucial for developing effective interventions.
Purpose of the Study:
- To investigate the pathogenesis of RSV and Mycoplasma pneumoniae infections in a pediatric population.
- To explore the relationship between age, immunity, and clinical disease severity.
Main Methods:
- Longitudinal observation of children at a day care center.
- Assessing immune responses through antibody titers and lymphocyte stimulation.
- Correlating infection patterns with clinical manifestations.
Main Results:
- A single RSV infection conferred modest, short-term resistance to reinfection.
- Mycoplasma pneumoniae infections were generally mild in young children, with frequent reinfections and antibody responses.
- Cellular immune responses to Mycoplasma pneumoniae were age-dependent, appearing later in childhood.
Conclusions:
- Clinical disease severity for both RSV and Mycoplasma pneumoniae appears modulated by the host's immune response and age.
- RSV vaccines might reduce disease severity rather than prevent infection.
- Mycoplasma pneumoniae vaccines could potentially enhance illness severity in children and should be used cautiously.
Abstract:
Longitudinal observations were made of a well-defined population of children at a day care center in an investigation of the pathogenesis of infections due to respiratory syncytial virus (RSV) and Mycoplasma pneumoniae. A single RSV infection induced a modest but significant degree of resistance to further RSV infection in these children. Age and immunity seemed to interact to decrease the intensity of the clinical expression of illness associated with RSV infection. Infants and young children had asymptomatic or mild infections with M. pneumoniae; some of these children also became reinfected. A rise in titer of antibody to M. pneumoniae was demonstrated frequently in children of all ages. However, stimulation of peripheral lymphocytes by M. pneumoniae antigen was demonstrated infrequently in children younger than four years of age but frequently in children older than four years of age. It is speculated that the clinical expression of disease due to M. pneumoniae is modulated by immune responses; this hypothesis would explain the greater severity of illness in older children and young adults than in younger children. It is also speculated that RSV vaccines will not prevent RSV infection but may be expected to lessen the severity of clinical disease that follows such infections. M. pneumoniae vaccines probably should not be used in children because these vaccines may enhance immunity and increase the sevrity of illness.
More Related Videos
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
10:30Immunocompetent Alveolus-on-Chip Model for Studying Alveolar Mucosal Immune Responses
Published on: May 31, 2024
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Microbiota of the Respiratory Tract
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features